Dr Reddy's Laboratories will announce its financial results for the quarter ended June 30, 2026, on Wednesday, July 22, 2026. The announcement will follow a Board Meeting and will be disseminated through stock exchanges, media, the company website, and email.

Management will host an earnings call at 19:30 IST (10:00 AM ET) to discuss the company's financial performance. Participants can pre-register for the call via a provided link. Audio and transcript of the earnings call will be available on the company's website after the event.

The schedule of events includes the release of financial results after the Board Meeting on July 22, 2026. The press meet presentation will be accessible on the company website. The earnings call will be hosted by the company management.

Schedule of Events

Investor relations contact is Aishwarya Sitharam, and media relations contact is Santosh Vyas.

Dr Reddy's Laboratories Ltd has scheduled its 42nd Annual General Meeting (AGM) for Thursday, July 23, 2026, at 11:00 a.m. IST through video conferencing. The Board of Directors has recommended a final dividend of ₹8 per equity share of the face value of ₹1 each for the financial year ended March 31, 2026. The dividend, if declared, will be paid on or before July 30, 2026, to members whose names appear on the Register of Members as of the end of the day on July 10, 2026.

The Notice and Integrated Annual Report for Financial Year 2025-26 were sent electronically on June 30, 2026. The AGM will transact ordinary business, including the adoption of audited financial statements for the financial year ended March 31, 2026. Shareholders will consider the re-appointment of Mr. K Satish Reddy, Director, who retires by rotation. The meeting will also seek approval to appoint M/s. Deloitte Haskins & Sells, LLP, as Statutory Auditors for a period of five consecutive years, replacing M/s. S. R. Batliboi & Associates LLP. The proposed audit fee for the financial year ending March 31, 2027, is ₹8,86,00,000 plus applicable taxes.

Special business includes the re-appointment of Dr. K P Krishnan as an Independent Director for a second term of five consecutive years effective from January 7, 2027, to January 6, 2032. Additionally, the appointment of Mr. Srikanth Velamakanni as an Independent Director for a term of five years effective from July 1, 2026, to June 30, 2031, will be put to vote. The company also seeks ratification for the remuneration payable to cost auditors, M/s. Sagar & Associates, amounting to ₹9,00,000 plus applicable taxes for the financial year ending March 31, 2027.

E-voting for the AGM commences on July 19, 2026, at 9:00 a.m. IST and concludes on July 22, 2026, at 5:00 p.m. IST. The cut-off date to determine shareholder eligibility for voting and dividend entitlement is July 16, 2026. The facility for attending the AGM virtually will be available for 1,000 members on a first-come, first-served basis, excluding large shareholders, promoters, and institutional investors.

Key AGM Dates and Details

The company has stated that the notice and the Integrated Annual Report have been sent electronically to members. Physical copies have not been dispatched. Shareholders can access the documents on the company's website.